Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review

Gynecologic Oncology
C J de WitteC G Gerestein

Abstract

Human papillomavirus (HPV) infection is in the vast majority of patients accountable for the development of vulvar, cervical and vaginal intraepithelial neoplasia (VIN, CIN, VAIN); precursors of vulvar, cervical and vaginal cancers. The currently preferred treatment modality for high grade VIN, CIN and VAIN is surgical excision. Nevertheless surgical treatment is associated with adverse pregnancy outcomes and recurrence is not uncommon. The aim of this review is to present evidence on the efficacy, safety and tolerability of imiquimod (an immune response modifier) in HPV-related VIN, CIN and VAIN. A search for papers on the use of imiquimod in VIN, CIN and VAIN was performed in the MEDLINE, EMBASE and Cochrane library databases. Data was extracted and reviewed. Twenty-one articles met the inclusion criteria and were analyzed; 16 on VIN, 3 on CIN and 2 on VAIN. Complete response rates in VIN ranged from 5 to 88%. Although minor adverse effects were frequently reported, treatment with imiquimod was well tolerated in most patients. Studies on imiquimod treatment of CIN and VAIN are limited and lack uniformly defined endpoints. The available evidence however, shows encouraging effect. Complete response rates for CIN 2-3 and VAIN 1-...Continue Reading

References

Jul 1, 1991·Cancer·M AhoJ Paavonen
Jun 16, 1993·Journal of the National Cancer Institute·M H SchiffmanS Wacholder
Jan 1, 1997·American Journal of Obstetrics and Gynecology·F H SillmanE McTigue
Dec 11, 1999·Proceedings of the Association of American Physicians·H zur Hausen
Apr 2, 2002·Gynecologic Oncology·Richard W ToddDavid M Luesley
Sep 22, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·D HaidopoulosA Intsaklis
Apr 25, 2006·Experimental Dermatology·Meinhard SchillerMatthias Gunzer
May 2, 2006·Obstetrics and Gynecology·Patricia L JudsonBeth A Virnig
Oct 20, 2006·Journal of Lower Genital Tract Disease·Henry W Buck, Kathy J Guth
Apr 28, 2007·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·I BruchimA Ferenczy
Dec 11, 2007·The British Journal of Dermatology·M P Schön, M Schön
Apr 4, 2008·The New England Journal of Medicine·Manon van SetersTheo J M Helmerhorst
Apr 15, 2008·Critical Reviews in Oncology/hematology·H P van de NieuwenhofJ A de Hullu
Aug 14, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ursula WintersHenry C Kitchener
Dec 31, 2008·International Journal of Cancer. Journal International Du Cancer·Hugo De VuystSilvia Franceschi
Dec 31, 2009·Journal of Lower Genital Tract Disease·Henry J HenkTheodore Darkow
Jul 27, 2010·International Journal of Cancer. Journal International Du Cancer·Annelinde TerlouLeen J Blok
Dec 12, 2012·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Claudia WestermannAndreas Clad
Feb 6, 2013·American Journal of Obstetrics and Gynecology·Camille C GundersonKathleen N Moore
Mar 16, 2013·BJOG : an International Journal of Obstetrics and Gynaecology·C N SpracklenA F Saftlas
Nov 10, 2013·Obstetrics and Gynecology·Shayna N ConnerGeorge A Macones

❮ Previous
Next ❯

Citations

Sep 21, 2016·Dermatologic Therapy·Antonio Martinez-LopezJesus Tercedor-Sanchez
Oct 27, 2016·The British Journal of Dermatology·A BarisaniS Vaccari
Dec 23, 2017·Journal of Lower Genital Tract Disease·Megan L FalsettaRichard P Phipps
Mar 6, 2018·The American Journal of Surgical Pathology·Natalia RakislovaUNKNOWN VVAP study group
Aug 20, 2018·International Journal of Cancer. Journal International Du Cancer·Gordana HalecAnna-Barbara Moscicki
Oct 31, 2018·Expert Opinion on Biological Therapy·Ziena AbdulrahmanMariette Ie Van Poelgeest
Apr 19, 2019·PloS One·Marie Francoise MukanyangeziDaniel Giglio
Oct 27, 2017·Proceedings of the National Academy of Sciences of the United States of America·Dorien Van HedeNathalie Jacobs
Jul 10, 2019·International Journal of STD & AIDS·Ioannis D GkegkesApostolos P Stamatiadis
Jun 10, 2017·Drug Delivery and Translational Research·Ian Major, Christopher McConville
Feb 8, 2019·IUBMB Life·Reyhaneh Moradi-MarjanehAmir Avan
May 10, 2016·Journal of Lower Genital Tract Disease·Ana Catarina Ferreira PolicianoCarlos Calhaz-Jorge
Aug 11, 2017·Therapeutic Advances in Vaccines·Sigrun SmolaPeter L Stern
Apr 26, 2016·Veterinary Dermatology·Luiza S ZakiaJosé P Oliveira-Filho
Jun 8, 2017·Advances in Anatomic Pathology·Natalia RakislovaJaume Ordi
Jul 1, 2020·International Journal of Clinical Practice·Argirios RountisDimitrios Haidopoulos
Oct 5, 2020·Gynecologic Oncology·Yoshihide InayamaKenzo Kosaka
Jan 29, 2021·Obstetrical & Gynecological Survey·Lauren E Dockery, John T Soper
Jan 29, 2021·Vaccines·Alessandro GhelardiElmar A Joura
May 18, 2020·Journal of Gynecology Obstetrics and Human Reproduction·M LebretonK Nyangoh-Timoh
Jun 15, 2021·Journal of Immunology Research·Saghar PahlavanneshanMohsen Basiri
Jul 20, 2021·Advanced Drug Delivery Reviews·José das NevesBruno Sarmento

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.